Canadian Oncology Today

Articles

• 

  The Evolution of PARP Inhibitors in Prostate Cancer

  Michael P. Kolinsky, MD, FRCPC

  5–11

  • PDF (en)
  • PDF (fr)
• 

  KRAS Inhibitors in Lung Cancer: Current Strategies and Future Approaches

  Kenneth G. Samala, MD, Quincy S-C Chu, MD, FRCPC

  12–21

  • PDF (en)
  • PDF (fr)
• 

  Early Age Onset Colorectal Cancer: A Canadian Perspective

  Michael J. Raphael, MD, FRCPC

  22–29

  • PDF (en)
  • PDF (fr)
• 

  Revolutionizing Breast Imaging: Artificial Intelligence’s Role in Precisely Differentiating Benign from Malignant Lesions

  Vivianne Freitas, MD, MSc., Renata Pinto, MD, MSc.

  30–34

  • PDF (en)
  • PDF (fr)
• 

  A Review of EGFR-Mutant Non‑Small Cell Lung Cancer (NSCLC) in 2024

  Florence Levesque, MD, Sophie Richard, MD, Nicolas Marcoux, MD

  36–42

  • PDF (en)
  • PDF (fr)